Patent · US Active

Opioid formulations

US11135215B2 · kind B2 · utility

2Cited by

47References

30Claims

0Family size

Assignee

CAMURUS AB · SE

Inventors

Fredrik Tiberg · Lund, SE
Ian Harwigsson · Lund, SE
Markus Johnsson · Lund, SE

Key dates

Filing date	Jan 6, 2021
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Jan 6, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A depot precursor formulation comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.